跳到主要导航 跳到搜索 跳到主要内容

Glucagon-like peptide 1-potentiated insulin secretion and proliferation of pancreatic β-cells

  • Xiaosong Ma*
  • , Youfei Guan
  • , Xianxin Hua
  • *此作品的通讯作者
  • Shenzhen University
  • University of Pennsylvania

科研成果: 期刊稿件 › 文献综述 › 同行评审

摘要

Glucagon-like peptide-1 (GLP-1) is the primary incretin hormone secreted from the intestine upon uptake of food to stimulate insulin secretion from pancreatic β-cells. GLP-1 exerts its effects by binding to its G-protein coupled receptors and subsequently activating adenylate cyclase, leading to generation of cyclic adenosine monophosphate (cAMP). cAMP stimulates insulin secretion via activation of its effectors PKA and Epac2 in pancreatic β-cells. In addition to its insulinotropic effects, GLP-1 also preserves pancreatic β-cell mass by stimulating β-cell proliferation. Unlike the action of sulphonylureas in lowering blood glucose levels, action of GLP-1 is affected by and interplays with glucose levels. Due to such advantages, GLP-1-based therapeutics have been rapidly developed and used clinically for treatment of type 2 diabetes. However, molecular mechanisms underlying how GLP-1 potentiates diminished glucose-stimulated insulin secretion and β-cell proliferation under diabetic conditions are not well understood. Here, we review the actions of GLP-1 in regulation of insulin secretion and pancreatic β-cell proliferation.

源语言英语
页(从-至)394-402
页数9
期刊Journal of Diabetes
卷6
期5
DOI
出版状态已出版 - 9月 2014
已对外发布是

联合国可持续发展目标

此成果有助于实现下列可持续发展目标:

  1. 可持续发展目标 3 - 良好健康与福祉
    可持续发展目标 3 良好健康与福祉

学术指纹

探究 'Glucagon-like peptide 1-potentiated insulin secretion and proliferation of pancreatic β-cells' 的科研主题。它们共同构成独一无二的学术指纹。

引用此